170 related articles for article (PubMed ID: 9205635)
1. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.
Kayath MJ; Vieira JG
Osteoporos Int; 1997; 7(3):226-30. PubMed ID: 9205635
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.
Scillitani A; Battista C; Chiodini I; Carnevale V; Fusilli S; Ciccarelli E; Terzolo M; Oppizzi G; Arosio M; Gasperi M; Arnaldi G; Colao A; Baldelli R; Ghiggi MR; Gaia D; Di Somma C; Trischitta V; Liuzzi A
Clin Endocrinol (Oxf); 2003 Jun; 58(6):725-31. PubMed ID: 12780749
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density of the axial skeleton in acromegaly.
Ho PJ; Fig LM; Barkan AL; Shapiro B
J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
[TBL] [Abstract][Full Text] [Related]
4. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
Madeira M; Neto LV; de Lima GA; Moreira RO; de Mendonça LM; Gadelha MR; Farias ML
Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
[TBL] [Abstract][Full Text] [Related]
5. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
[TBL] [Abstract][Full Text] [Related]
6. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Eur J Endocrinol; 2005 Jan; 152(1):53-60. PubMed ID: 15762187
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.
Tütüncü NB; Erbaş T
Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):328-32. PubMed ID: 15216451
[TBL] [Abstract][Full Text] [Related]
8. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study.
Battista C; Chiodini I; Muscarella S; Guglielmi G; Mascia ML; Carnevale V; Scillitani A
Clin Endocrinol (Oxf); 2009 Mar; 70(3):378-82. PubMed ID: 18616713
[TBL] [Abstract][Full Text] [Related]
9. Bone metabolism and body composition in Japanese patients with active acromegaly.
Kaji H; Sugimoto T; Nakaoka D; Okimura Y; Kaji H; Abe H; Chihara K
Clin Endocrinol (Oxf); 2001 Aug; 55(2):175-81. PubMed ID: 11531923
[TBL] [Abstract][Full Text] [Related]
10. Gonadal status is an important determinant of bone density in acromegaly.
Lesse GP; Fraser WD; Farquharson R; Hipkin L; Vora JP
Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and parameters of bone metabolism in patients with acromegaly.
Kotzmann H; Bernecker P; Hübsch P; Pietschmann P; Woloszczuk W; Svoboda T; Geyer G; Luger A
J Bone Miner Res; 1993 Apr; 8(4):459-65. PubMed ID: 8475795
[TBL] [Abstract][Full Text] [Related]
12. Trabecular bone score as a skeletal fragility index in acromegaly patients.
Hong AR; Kim JH; Kim SW; Kim SY; Shin CS
Osteoporos Int; 2016 Mar; 27(3):1123-1129. PubMed ID: 26446771
[TBL] [Abstract][Full Text] [Related]
13. The effects of high serum growth hormone and IGF-1 levels on bone mineral density in acromegaly.
Tuzcu S; Durmaz ŞA; Carlıoğlu A; Demircan Z; Tuzcu A; Beyaz C; Tay A
Z Rheumatol; 2017 Oct; 76(8):716-722. PubMed ID: 27766418
[TBL] [Abstract][Full Text] [Related]
14. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism.
Diamond T; Nery L; Posen S
Ann Intern Med; 1989 Oct; 111(7):567-73. PubMed ID: 2774387
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.
Bolanowski M; Daroszewski J; Medraś M; Zadrozna-Sliwka B
J Bone Miner Metab; 2006; 24(1):72-8. PubMed ID: 16369902
[TBL] [Abstract][Full Text] [Related]
16. The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition.
Howell SJ; Radford JA; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 2000 May; 52(5):609-16. PubMed ID: 10792341
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and magnitude of osteopenia in patients with prolactinoma.
Kayath MJ; Lengyel AM; Vieira JG
Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
[TBL] [Abstract][Full Text] [Related]
18. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men.
Krassas GE; Papadopoulou P; Koliakos G; Konstantinidis T; Kalothetou K
Arch Androl; 2003; 49(3):191-9. PubMed ID: 12746097
[TBL] [Abstract][Full Text] [Related]
20. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
